title: PET/CT in the imaging of ovarian Cancer.
abstract: Ovarian cancer is responsible for the largest proportion of deaths among patients with gynecologic cancer. This paper discusses fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the imaging of ovarian cancer. We discuss and demonstrate how FDG PET/CT can be used to appropriately guide clinical management decisions in patients with ovarian cancer. In particular, FDG PET/CT shows great promise for the preoperative evaluation of women with primary ovarian cancer and for subsequent postoperative assessment for recurrence.
authors.affiliation: Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.
authors.forename: Owen Joseph
authors.initials: OJ
authors.lastname: O'Connor
authors.forename: Priyanka
authors.initials: P
authors.lastname: Prakash
authors.forename: Carmel G
authors.initials: CG
authors.lastname: Cronin
authors.forename: Shaunagh
authors.initials: S
authors.lastname: McDermott
authors.forename: Michael Austin
authors.initials: MA
authors.lastname: Blake
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D064847:Multimodal Imaging / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D009367:Neoplasm Staging / Q000379:methods*; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000648:ultrastructure*; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18